Tiefenbacher Pharmaceuticals, a part of Tiefenbacher Group, at CPHI Barcelona 2023
We are pleased to say that we have had three very successful days full of inspiring meetings CPHI Barcelona 2023. A big thanks to all who visited us in Barcelona. It was wonderful to meet many familiar and new faces and we are already looking forward to seeing you again next year in Milan!
Thank you to our colleagues from our three main locations in Hamburg (Germany), Hyderabad (India) and Lefkosia (Cyprus) for making this expo so special.
The Tiefenbacher Group participated in the CPhI, the world’s leading event for the pharmaceutical industry, from October 24 to 26 in Barcelona! Where visitors could explore the new booth of Tiefenbacher and discover our latest product portfolio and innovations in the field of raw materials, finished dosage forms, and medical devices! This was the opportunity to get in touch with many of our experts to discuss new business opportunities and ideas for making pharmaceuticals more affordable, more available, and better than before!
TIEFENBACHER PHARMACEUTICALS, a part of Tiefenbacher Group, develops and commercializes generic, value added, and innovative pharmaceuticals as well as medical devices and e-health solutions worldwide. We provide over 180+ pharmaceutical products across various therapeutic categories in 10+ dosage forms. With our in-house product development and manufacturing, we can address specific therapeutic needs in unique formulations of prescription drugs (Rx) and over-the-counter (OTC) medicines for global markets.
For more information about our finished dosage forms (FDF) including highly potent drugs and healthcare solutions, please contact Tiefenbacher Pharmaceuticals: info@tiefenbacher.com or visit us on: www.tiefenbacher-pharmaceuticals.com
